| $376M | ||
| $350M | ||
| $215M | ||
| $107M | ||
| $100M | ||
| $99M |
Buys | $0 | 0 | 0 |
Sells | $57,835 | 3 | 100 |
| Macko Todd D | Chief Financial Officer | 0 | $0 | 2 | $25,330 | $-25,330 |
| Grady Jason | director | 0 | $0 | 1 | $32,505 | $-32,505 |
Houston, Texas-based Impact BioMedical Inc., founded in 2018, focuses on discovering and developing innovative products and therapeutic options for both specialty biopharmaceuticals and consumer healthcare markets. The company features several key technologies: its "Linebacker" platform utilizes small molecule electrophilically enhanced polyphenol compounds with potential applications in treating cancer, inflammatory diseases, and neurological conditions. Additionally, "Laetose" technology, a unique blend of sugar and inositol, is designed to counteract the inflammatory and metabolic responses usually triggered by sugar consumption. Impact BioMedical also creates "functional fragrance formulations," which are a series of fragrances incorporating specialized botanical ingredients for antimicrobial purposes, or as active additives in items like insect repellents, cleaning products, personal care items, and fabrics. Rounding out its offerings is the "Equivir/Equivir G" technology, a distinctive mix of polyphenols that has exhibited antiviral properties, suitable for use in health supplements and medications.
Over the last 12 months, insiders at Impact BioMedical Inc. have bought $0 and sold $57,835 worth of Impact BioMedical Inc. stock.
On average, over the past 5 years, insiders at Impact BioMedical Inc. have bought $161,033 and sold $2.87M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 200 shares for transaction amount of $310 was made by DSS, INC. (10 percent owner) on 2025‑03‑20.
| 2026-03-27 | Sale | Macko Todd D | Chief Financial Officer | 43,400 0.3487% | $0.56 | $24,369 | +8.73% | |
| 2026-03-25 | Sale | Macko Todd D | Chief Financial Officer | 1,600 0.0132% | $0.60 | $961 | +6.28% | |
| 2026-03-23 | Sale | Grady Jason | director | 50,000 0.402% | $0.65 | $32,505 | -4.62% | |
| 2025-05-27 | Sale | DSS, INC. | 10 percent owner | 45,400 0.3798% | $0.54 | $24,530 | +7.41% | |
| 2025-05-22 | Sale | DSS, INC. | 10 percent owner | 115,600 0.955% | $0.55 | $63,476 | +4.36% | |
| 2025-04-04 | Sale | DSS, INC. | 10 percent owner | 890,800 7.7532% | $0.95 | $845,013 | -42.95% | |
| 2025-04-03 | Sale | Chan Heng Fai Ambrose | director | 351,555 3.2601% | $0.49 | $174,020 | +18.39% | |
| 2025-04-01 | Sale | Chan Heng Fai Ambrose | 2.23M 15.8023% | $1.17 | $2.6M | -33.02% | ||
| 2025-03-31 | Sale | Chan Heng Fai Ambrose | 300,000 3.0814% | $1.03 | $308,400 | -36.87% | ||
| 2025-03-27 | Sale | DSS, INC. | 10 percent owner | 47,681 0.4547% | $2.50 | $119,255 | -75.91% | |
| 2025-03-26 | Sale | DSS, INC. | 10 percent owner | 58,139 0.7196% | $3.13 | $182,134 | -75.04% | |
| 2025-03-21 | Sale | DSS, INC. | 10 percent owner | 333,200 1.9273% | $3.30 | $1.1M | -88.93% | |
| 2025-03-20 | Sale | DSS, INC. | 10 percent owner | 53,280 1.0421% | $4.68 | $249,350 | -73.60% | |
| 2025-03-20 | DSS, INC. | 10 percent owner | 200 0.0013% | $1.55 | $310 | -73.60% | ||
| 2024-12-05 | Heuszel Frank D | Chief Executive Officer | 500 0.0043% | $2.26 | $1,129 | -72.91% | ||
| 2024-12-02 | Sale | DSS, INC. | 10 percent owner | 20 0.0002% | $2.90 | $58 | -75.24% | |
| 2024-11-27 | Heuszel Frank D | Chief Executive Officer | 500 0.0041% | $2.61 | $1,305 | -76.89% | ||
| 2024-11-26 | Heuszel Frank D | Chief Executive Officer | 1,050 0.0087% | $2.61 | $2,739 | -76.71% | ||
| 2024-11-18 | Sale | DSS, INC. | 10 percent owner | 5,000 0.0432% | $3.02 | $15,085 | -78.78% | |
| 2024-11-13 | Sale | DSS, INC. | 10 percent owner | 200 0.0019% | $2.80 | $560 | -76.96% |
| Increased Positions | 10 | +45.45% | 933,246 | +173.4% |
| Decreased Positions | 7 | -31.82% | 31,602 | -5.87% |
| New Positions | 4 | New | 175,667 | New |
| Sold Out Positions | <1 | Sold Out | 36 | Sold Out |
| Total Postitions | 25 | +13.64% | 1M | +167.52% |
| Blackrock, Inc. | $131.00 | 0.24% | 252,730 | 0 | 0% | 2025-09-30 |
| Vanguard Group Inc | $53.00 | 0.1% | 102,905 | +70,468 | +217.25% | 2025-09-30 |
| Geode Capital Management, Llc | $23.00 | 0.04% | 45,109 | -4,760 | -9.54% | 2025-09-30 |
| Two Sigma Investments, Lp | $16.00 | 0.03% | 31,500 | +8,800 | +38.77% | 2025-09-30 |
| Two Sigma Securities, Llc | $15.00 | 0.03% | 28,441 | +28,441 | New | 2025-09-30 |
| Susquehanna International Group, Llp | $11.00 | 0.02% | 20,962 | -9,862 | -32% | 2025-09-30 |
| Ubs Group Ag | $10.00 | 0.02% | 20,088 | -19,637 | -49.43% | 2025-09-30 |
| State Street Corp | $6.00 | 0.01% | 11,797 | 0 | 0% | 2025-09-30 |
| Mason & Associates Inc | $5.00 | 0.01% | 10,000 | +10,000 | New | 2025-09-30 |
| Morgan Stanley | $5.00 | 0.01% | 9,266 | +9,266 | New | 2025-09-30 |